Becton, Dickinson and (BDX) Stock: Charts & Financials

Becton, Dickinson and Company (BDX)BDXBecton, Dickinson and Company

About Becton, Dickinson and Company

Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world. The BD Medical division delivers a comprehensive suite of products primarily focused on medication management and drug delivery. This encompasses a variety of intravenous (IV) access solutions, such as peripheral and advanced catheters, central lines, acute dialysis catheters, and related vascular care items including needle-free connectors and closed-system drug transfer devices. It also provides essential injection equipment like hypodermic syringes, needles, anesthesia trays, enteral syringes, and sharps disposal systems. Additionally, this segment develops integrated systems for IV medication and infusion therapy, medication compounding workflow, automated dispensing, and supply chain optimization. Specialized products for diabetes management, including pen needles, along with prefillable drug delivery systems, are also key offerings. BD Life Sciences focuses on diagnostic and research tools, offering products for specimen and blood collection. This segment supplies automated systems for culturing blood and tuberculosis, molecular testing, microorganism identification, and drug susceptibility analysis. It also provides liquid-based cytology systems, rapid diagnostic assays, microbiology laboratory automation, and plated media. Furthermore, it offers advanced solutions for cell analysis, including fluorescence-activated cell sorters and analyzers, antibodies, kits, and reagent systems. These are crucial for single-cell gene expression analysis, as well as for clinical oncology, immunological, and transplantation diagnostics and monitoring. Finally, the BD Interventional segment delivers specialized products for surgical and interventional procedures. Its portfolio includes solutions for hernia and soft tissue repair, biological and bioresorbable grafts, and biosurgery, alongside other surgical products. This segment also addresses surgical infection prevention, provides a range of surgical and laparoscopic instrumentation, offers peripheral intervention products, and supplies urology and critical care devices. Established in 1897, the company maintains its headquarters in Franklin Lakes, New Jersey.

Franklin Lakes, NJ

72,000 employees

www.bd.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Thomas E. Polen Jr.

View full financials

Quarterly Report	TTM	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024	Quarter ended Jun 2024
Total Current Assets	8.01B	8.01B	9.19B	9.26B	9.00B	8.67B	8.66B	10.47B	12.21B
Cash & Cash Equivalents	813.00M	813.00M	1.02B	851.00M	735.00M	667.00M	711.00M	1.86B	4.46B
Short-Term Investments	3.00M	3.00M	11.00M	8.00M	22.00M	16.00M	17.00M	445.00M	851.00M
Cash & Short-Term Investments	816.00M	816.00M	1.03B	859.00M	757.00M	683.00M	728.00M	2.30B	5.31B
Accounts Receivable	2.21B	2.21B	2.51B	2.99B	2.94B	3.03B	2.64B	3.03B	2.60B
Inventory	3.36B	3.36B	4.08B	3.89B	3.95B	3.72B	3.86B	3.84B	3.25B
Total Assets	50.83B	50.83B	54.84B	55.33B	54.90B	54.47B	54.66B	57.29B	55.58B
Property, Plant & Equipment	6.08B	6.08B	6.97B	7.00B	6.82B	6.65B	6.60B	6.82B	6.52B
Goodwill	25.95B	25.95B	26.62B	33.02B	26.60B	26.44B	26.33B	26.46B	24.55B
Intangible Assets	8.35B	8.35B	9.03B	2.99B	9.79B	10.13B	10.49B	10.92B	9.91B
Long-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	8.51B	8.51B	8.76B	8.31B	8.16B	7.69B	7.66B	8.96B	6.61B
Accounts Payable	0.00	0.00	6.14B	1.97B	6.35B	6.09B	6.35B	1.90B	4.96B
Short-Term Debt	2.57B	2.57B	2.62B	1.56B	1.81B	1.60B	1.32B	2.31B	1.19B
Total Liabilities	26.70B	26.70B	29.56B	29.94B	29.43B	29.23B	29.46B	31.40B	29.71B
Long-Term Debt	14.71B	14.71B	16.92B	17.62B	17.53B	17.67B	17.44B	18.61B	18.13B
Total Debt	17.28B	17.28B	19.54B	19.18B	19.34B	19.27B	18.76B	21.59B	19.32B
Net Debt (Cash)	16.47B	16.47B	18.52B	18.33B	18.61B	18.60B	18.05B	19.73B	14.86B
Total Shareholders' Equity	24.13B	24.13B	25.28B	25.39B	25.47B	25.24B	25.20B	25.89B	25.87B
Common Stock	371.00M	371.00M	371.00M	371.00M	371.00M	371.00M	371.00M	371.00M	371.00M
Retained Earnings	17.39B	17.39B	16.70B	16.62B	16.43B	16.15B	16.14B	16.14B	16.02B
Current Ratio	0.94	0.94	1.05	1.11	1.10	1.13	1.13	1.17	1.85
Debt to Equity Ratio	0.72	0.72	0.77	0.76	0.76	0.76	0.74	0.83	0.75

Quarterly Report

TTM

Quarter ended Mar 2026

Quarter ended Dec 2025

Quarter ended Sep 2025

Quarter ended Jun 2025

Quarter ended Mar 2025

Quarter ended Dec 2024

Quarter ended Sep 2024

Quarter ended Jun 2024

Total Current Assets

8.01B

9.19B

9.26B

9.00B

8.67B

8.66B

10.47B

12.21B

Cash & Cash Equivalents

813.00M

1.02B

851.00M

735.00M

667.00M

711.00M

1.86B

4.46B

Short-Term Investments

3.00M

11.00M

8.00M

22.00M

16.00M

17.00M

445.00M

851.00M

Cash & Short-Term Investments

816.00M

1.03B

859.00M

757.00M

683.00M

728.00M

2.30B

5.31B

Accounts Receivable

2.21B

2.51B

2.99B

2.94B

3.03B

2.64B

3.03B

2.60B

Inventory

3.36B

4.08B

3.89B

3.95B

3.72B

3.86B

3.84B

3.25B

Total Assets

50.83B

54.84B

55.33B

54.90B

54.47B

54.66B

57.29B

55.58B

Property, Plant & Equipment

6.08B

6.97B

7.00B

6.82B

6.65B

6.60B

6.82B

6.52B

Goodwill

25.95B

26.62B

33.02B

26.60B

26.44B

26.33B

26.46B

24.55B

Intangible Assets

8.35B

9.03B

2.99B

9.79B

10.13B

10.49B

10.92B

9.91B

Long-Term Investments

0.00

Total Current Liabilities

8.51B

8.76B

8.31B

8.16B

7.69B

7.66B

8.96B

6.61B

Accounts Payable

0.00

6.14B

1.97B

6.35B

6.09B

6.35B

1.90B

4.96B

Short-Term Debt

2.57B

2.62B

1.56B

1.81B

1.60B

1.32B

2.31B

1.19B

Total Liabilities

26.70B

29.56B

29.94B

29.43B

29.23B

29.46B

31.40B

29.71B

Long-Term Debt

14.71B

16.92B

17.62B

17.53B

17.67B

17.44B

18.61B

18.13B

Total Debt

17.28B

19.54B

19.18B

19.34B

19.27B

18.76B

21.59B

19.32B

Net Debt (Cash)

16.47B

18.52B

18.33B

18.61B

18.60B

18.05B

19.73B

14.86B

Total Shareholders' Equity

24.13B

25.28B

25.39B

25.47B

25.24B

25.20B

25.89B

25.87B

Common Stock

371.00M

Retained Earnings

17.39B

16.70B

16.62B

16.43B

16.15B

16.14B

16.02B

Current Ratio

0.94

1.05

1.11

1.10

1.13

1.17

1.85

Debt to Equity Ratio

0.72

0.77

0.76

0.74

0.83

0.75

Annual Report	09/30/2025	09/30/2024	09/30/2023	09/30/2022	09/30/2021	09/30/2020	09/30/2019	09/30/2018
Total Current Assets	9.26B	10.47B	8.68B	8.14B	8.84B	8.97B	6.64B	7.41B
Cash & Cash Equivalents	851.00M	1.86B	1.42B	1.16B	2.39B	2.83B	536.00M	1.14B
Short-Term Investments	8.00M	445.00M	8.00M	8.00M	12.00M	20.00M	30.00M	17.00M
Cash & Short-Term Investments	859.00M	2.30B	1.42B	1.17B	2.40B	2.85B	566.00M	1.16B
Accounts Receivable	2.99B	3.03B	2.53B	2.19B	2.35B	2.40B	2.35B	2.32B
Inventory	3.89B	3.84B	3.27B	3.22B	2.74B	2.74B	2.58B	2.45B
Total Assets	55.33B	57.29B	52.78B	52.93B	53.88B	54.01B	51.84B	53.90B
Property, Plant & Equipment	7.00B	6.82B	6.56B	6.01B	6.00B	5.92B	5.66B	5.38B
Goodwill	33.02B	26.46B	24.52B	24.62B	23.89B	23.62B	23.38B	23.60B
Intangible Assets	2.99B	10.92B	10.95B	12.31B	12.78B	13.81B	14.98B	16.44B
Long-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	8.31B	8.96B	6.64B	7.81B	6.63B	5.84B	5.66B	7.22B
Accounts Payable	1.97B	1.90B	1.64B	1.70B	1.74B	1.35B	1.09B	1.11B
Short-Term Debt	1.56B	2.31B	1.26B	2.30B	626.00M	706.00M	1.31B	2.60B
Total Liabilities	29.94B	31.40B	26.98B	27.65B	30.20B	30.25B	30.68B	32.91B
Long-Term Debt	17.62B	18.61B	15.15B	14.27B	17.45B	17.22B	18.08B	18.89B
Total Debt	19.18B	21.59B	16.82B	16.95B	18.42B	17.93B	19.39B	21.50B
Net Debt (Cash)	18.33B	19.73B	15.34B	15.79B	16.03B	15.11B	18.85B	20.36B
Total Shareholders' Equity	25.39B	25.89B	25.80B	25.28B	23.68B	23.77B	21.08B	20.99B
Common Stock	371.00M	371.00M	371.00M	365.00M	365.00M	365.00M	347.00M	347.00M
Retained Earnings	16.62B	16.14B	15.54B	15.16B	13.83B	12.79B	12.91B	12.59B
Current Ratio	1.11	1.17	1.31	1.04	1.33	1.54	1.17	1.03
Debt to Equity Ratio	0.76	0.83	0.65	0.67	0.78	0.75	0.92	1.02

Annual Report

09/30/2025

09/30/2024

09/30/2023

09/30/2022

09/30/2021

09/30/2020

09/30/2019

09/30/2018

Total Current Assets

9.26B

10.47B

8.68B

8.14B

8.84B

8.97B

6.64B

7.41B

Cash & Cash Equivalents

851.00M

1.86B

1.42B

1.16B

2.39B

2.83B

536.00M

1.14B

Short-Term Investments

8.00M

445.00M

8.00M

12.00M

20.00M

30.00M

17.00M

Cash & Short-Term Investments

859.00M

2.30B

1.42B

1.17B

2.40B

2.85B

566.00M

1.16B

Accounts Receivable

2.99B

3.03B

2.53B

2.19B

2.35B

2.40B

2.35B

2.32B

Inventory

3.89B

3.84B

3.27B

3.22B

2.74B

2.58B

2.45B

Total Assets

55.33B

57.29B

52.78B

52.93B

53.88B

54.01B

51.84B

53.90B

Property, Plant & Equipment

7.00B

6.82B

6.56B

6.01B

6.00B

5.92B

5.66B

5.38B

Goodwill

33.02B

26.46B

24.52B

24.62B

23.89B

23.62B

23.38B

23.60B

Intangible Assets

2.99B

10.92B

10.95B

12.31B

12.78B

13.81B

14.98B

16.44B

Long-Term Investments

0.00

Total Current Liabilities

8.31B

8.96B

6.64B

7.81B

6.63B

5.84B

5.66B

7.22B

Accounts Payable

1.97B

1.90B

1.64B

1.70B

1.74B

1.35B

1.09B

1.11B

Short-Term Debt

1.56B

2.31B

1.26B

2.30B

626.00M

706.00M

1.31B

2.60B

Total Liabilities

29.94B

31.40B

26.98B

27.65B

30.20B

30.25B

30.68B

32.91B

Long-Term Debt

17.62B

18.61B

15.15B

14.27B

17.45B

17.22B

18.08B

18.89B

Total Debt

19.18B

21.59B

16.82B

16.95B

18.42B

17.93B

19.39B

21.50B

Net Debt (Cash)

18.33B

19.73B

15.34B

15.79B

16.03B

15.11B

18.85B

20.36B

Total Shareholders' Equity

25.39B

25.89B

25.80B

25.28B

23.68B

23.77B

21.08B

20.99B

Common Stock

371.00M

365.00M

347.00M

Retained Earnings

16.62B

16.14B

15.54B

15.16B

13.83B

12.79B

12.91B

12.59B

Current Ratio

1.11

1.17

1.31

1.04

1.33

1.54

1.17

1.03

Debt to Equity Ratio

0.76

0.83

0.65

0.67

0.78

0.75

0.92

1.02

Balance Sheet

Quarterly Balance Sheet (USD)

Annual Balance Sheet (USD)